<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hu L</submitter><funding>National Key R&amp;D Program of China</funding><funding>Guangdong Basic and Applied Basic Research Foundation</funding><funding>Basic and Applied Basic Research Foundation of Guangdong Province</funding><funding>National Natural Science Foundation of China</funding><funding>National Key Research and Development Program of China</funding><funding>Science and Technology Project of Guangzhou City</funding><pagination>e10597</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12752648</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(48)</volume><pubmed_abstract>Viral receptors are essential host factors that determine the tropism of oncolytic viruses, and contribute to their selective targeting of cancer cells. In this study, a membrane protein-targeted CRISPR-Cas9 screen is conducted and identify transmembrane protein adipocyte-associated 1 (TPRA1) as a novel receptor for oncolytic virus M1(OVM), a promising oncolytic virus currently under clinical investigation. Mechanistically, TPRA1 facilitates OVM infection by promoting both viral attachment and internalization. Extracellular region of TPRA1 directly binds OVM particles via glycosylation, while its cytoplasmic tail mediates virus endocytosis, collectively enabling efficient viral entry and cancer cell lysis. Importantly, TPRA1 expression in cell lines, mouse models, and patient-derived tumor</pubmed_abstract><journal>Advanced science (Weinheim, Baden-Wurttemberg, Germany)</journal><pubmed_title>Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1.</pubmed_title><pmcid>PMC12752648</pmcid><funding_grant_id>2023A03J0200</funding_grant_id><funding_grant_id>2022B1515020056</funding_grant_id><funding_grant_id>82204447</funding_grant_id><funding_grant_id>82373285</funding_grant_id><funding_grant_id>2021YFA0909800</funding_grant_id><funding_grant_id>82473324</funding_grant_id><funding_grant_id>2024A1515010317</funding_grant_id><pubmed_authors>Zhang G</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Yin W</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Fan Z</pubmed_authors><pubmed_authors>Song D</pubmed_authors><pubmed_authors>Cai J</pubmed_authors><pubmed_authors>Yi S</pubmed_authors><pubmed_authors>Lin X</pubmed_authors><pubmed_authors>Lin Y</pubmed_authors><pubmed_authors>Zeng Y</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Liu Z</pubmed_authors><pubmed_authors>Huang S</pubmed_authors><pubmed_authors>Hu C</pubmed_authors><pubmed_authors>Hu J</pubmed_authors><pubmed_authors>Liang J</pubmed_authors><pubmed_authors>Hu L</pubmed_authors><pubmed_authors>Zhu W</pubmed_authors><pubmed_authors>Yan G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1.</name><description>Viral receptors are essential host factors that determine the tropism of oncolytic viruses, and contribute to their selective targeting of cancer cells. In this study, a membrane protein-targeted CRISPR-Cas9 screen is conducted and identify transmembrane protein adipocyte-associated 1 (TPRA1) as a novel receptor for oncolytic virus M1(OVM), a promising oncolytic virus currently under clinical investigation. Mechanistically, TPRA1 facilitates OVM infection by promoting both viral attachment and internalization. Extracellular region of TPRA1 directly binds OVM particles via glycosylation, while its cytoplasmic tail mediates virus endocytosis, collectively enabling efficient viral entry and cancer cell lysis. Importantly, TPRA1 expression in cell lines, mouse models, and patient-derived tumor</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-07-15T13:51:53.894Z</modification><creation>2026-07-05T03:11:30.503Z</creation></dates><accession>S-EPMC12752648</accession><cross_references><pubmed>41053536</pubmed><doi>10.1002/advs.202510597</doi></cross_references></HashMap>